Dov V. Shimon
Vorstandsvorsitzender bei Sagax Medical Technologies, Inc.
Profil
Dov V.
Shimon is the founder of Sagax Medical Technologies, Inc. (founded in 2002) and Keystone Heart Ltd.
(founded in 2004).
At Sagax Medical Technologies, Inc., he holds the title of President & Chief Executive Officer.
At Keystone Heart Ltd., he held the title of President & Chief Medical Officer from 2004 to 2012.
Dr. Shimon also has former job experience as the Director of the Utah Artificial Heart Institute and as the Chief Medical Officer of MIV Therapeutics, Inc. Additionally, he obtained his undergraduate degree from The Hebrew University of Jerusalem in 1976.
Aktive Positionen von Dov V. Shimon
| Unternehmen | Position | Beginn |
|---|---|---|
Sagax Medical Technologies, Inc.
 Sagax Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Part of Shimoco LLC, Sagax Medical Technologies, Inc. develops proprietary solutions to reduce the risk of strokes and other serious complications resulting from cardiac procedures, as well as naturally occurring Cardioembolic Strokes. The company is based in Herzliya, Israel. The Israeli company was founded by Dov V. Shimon, who has been the CEO since incorporation. Sagax Medical Technologies was acquired by Shimoco LLC from MIV Therapeutics, Inc. on December 28, 2007. | Vorstandsvorsitzender | 01.01.2002 |
Ehemalige bekannte Positionen von Dov V. Shimon
| Unternehmen | Position | Ende |
|---|---|---|
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Gründer | 25.04.2012 |
MIV Therapeutics, Inc.
 MIV Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services MIV Therapeutics, Inc. is an advanced stage, research and development company. It is engaged in developing a next-generation line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and for a broad range of other implantable medical devices. The company was founded by Alan P. Lindsay on January 20, 1999 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 13.11.2007 |
| Utah Artificial Heart Institute | Direktor/Vorstandsmitglied | - |
Ausbildung von Dov V. Shimon
| The Hebrew University of Jerusalem | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
MIV Therapeutics, Inc.
MIV Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services MIV Therapeutics, Inc. is an advanced stage, research and development company. It is engaged in developing a next-generation line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and for a broad range of other implantable medical devices. The company was founded by Alan P. Lindsay on January 20, 1999 and is headquartered in Vancouver, Canada. | Commercial Services |
Sagax Medical Technologies, Inc.
Sagax Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Part of Shimoco LLC, Sagax Medical Technologies, Inc. develops proprietary solutions to reduce the risk of strokes and other serious complications resulting from cardiac procedures, as well as naturally occurring Cardioembolic Strokes. The company is based in Herzliya, Israel. The Israeli company was founded by Dov V. Shimon, who has been the CEO since incorporation. Sagax Medical Technologies was acquired by Shimoco LLC from MIV Therapeutics, Inc. on December 28, 2007. | Health Technology |
| Utah Artificial Heart Institute | |
Keystone Heart Ltd.
Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Health Technology |
